Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

35.87 +0.17 (+0.48%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Baxter International

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Baxter publishes annual corporate responsibility report, highlighting continued focus on creating lasting impact
From Baxter International Inc.
Via Business Wire
3 Bargain Bin Stocks with Millionaire-Maker Potential
Three bargain stocks with substantial upside from potential price-to-earnings multiple reratings and accretive buybacks. 
Via InvestorPlace
Carlyle Eyes $4B Acquisition Of Baxter's Kidney-Care Unit Vantive: Report
Carlyle is negotiating to acquire Baxter International's kidney-care spinoff, Vantive, in a $4 billion deal, including debt. The deal reflects a significant move in private-equity dealmaking and... 
Via Benzinga
“Cash Flow Is The Name Of The Game” Stock Market
Liquidity is becoming a problem and the Fed (and other Central Bankers) know it. Higher for longer is a luxury they can no longer afford. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Assessing Baxter Intl: Insights From 4 Financial Analysts
Via Benzinga
How Is The Market Feeling About Baxter Intl?
Via Benzinga
Unveiling 5 Analyst Insights On Baxter Intl
Via Benzinga
(BAX) - Analyzing Baxter Intl's Short Interest
Via Benzinga
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
7 Deeply Undervalued Stocks to Buy Now or Regret Later
Unlock massive upside by buying these deeply undervalued stocks at fire-sale prices. These companies have staying power and could bounce back. 
Via InvestorPlace
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
From Baxter International Inc.
Via Business Wire
3 Dividend Growth Stocks For Long-Term Returns
One way to measure the quality of a dividend stock is by its dividend history. Stocks with established histories of dividend growth may be likely to continue growing their dividends moving forward.... 
Via Talk Markets
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts
Via Benzinga
3 Dividend Stocks For 10%+ Annual Returns
Buying undervalued dividend stocks with growth potential could lead to above-average returns. 
Via Talk Markets
Assessing Baxter Intl: Insights From 4 Financial Analysts
Via Benzinga
Baxter to Present at Jefferies 2024 Global Healthcare Conference
From Baxter International Inc.
Via Business Wire
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and... 
Via Benzinga
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
From Baxter International Inc.
Via Business Wire
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
From Baxter International Inc.
Via Business Wire
Baxter to Present at Bank of America 2024 Health Care Conference
From Baxter International Inc.
Via Business Wire
Baxter Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Why Is Nuvo Group (NUVO) Stock Up 200% Today?
Although prenatal care specialist Nuvo Group saw its shares soar on Monday, NUVO stock faces skepticism over its SPAC merger. 
Via InvestorPlace
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses. 
Via InvestorPlace
Why Is Medical Device Maker Baxter Stock Trading Lower On Thursday?
Baxter reports Q1 adjusted EPS at $0.65, up 10% Y/Y, surpassing expectations. Sales hit $3.59 billion, with 2% growth on a reported basis. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
BAX Stock Earnings: Baxter Intl Beats EPS, Beats Revenue for Q1 2024
BAX stock results show that Baxter Intl beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Baxter Reports First-Quarter 2024 Results
From Baxter International Inc.
Via Business Wire
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducing cognitive burden. Explore enhanced safety features & EMR interoperability. 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.